APA (7th ed.) Citation

El-Taji, O., D., M., Jones, C., Hoyle, A., Brown, M., Pickhardt, P., . . . Clarke, N. (2025). P189 – Quantitative CT measurement of abdominal aortic calcium as a novel prognostic biomarker for non-cancer mortality: Post-hoc analysis of the STAMPEDE docetaxel and abiraterone acetate plus prednisone phase 3 trials. European urology, 87, S192. https://doi.org/10.1016/j.eururo.2025.09.2643

Chicago Style (17th ed.) Citation

El-Taji, O., et al. "P189 – Quantitative CT Measurement of Abdominal Aortic Calcium as a Novel Prognostic Biomarker for Non-cancer Mortality: Post-hoc Analysis of the STAMPEDE Docetaxel and Abiraterone Acetate Plus Prednisone Phase 3 Trials." European Urology 87 (2025): S192. https://doi.org/10.1016/j.eururo.2025.09.2643.

MLA (9th ed.) Citation

El-Taji, O., et al. "P189 – Quantitative CT Measurement of Abdominal Aortic Calcium as a Novel Prognostic Biomarker for Non-cancer Mortality: Post-hoc Analysis of the STAMPEDE Docetaxel and Abiraterone Acetate Plus Prednisone Phase 3 Trials." European Urology, vol. 87, 2025, p. S192, https://doi.org/10.1016/j.eururo.2025.09.2643.